SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer

NCT00020774 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: lonafarnib
PROCEDURE: conventional surgery

Sponsor

Jonsson Comprehensive Cancer Center